Stay updated on Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.

Latest updates to the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page
- Check2 days agoChange DetectedThe revision entry updates from v3.6.3 to v3.6.4 in the record history. This reflects a minor update to the page's revision metadata.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.6.3 was added and Revision: v3.6.2 was removed from the history, updating the list to reflect the latest release.SummaryDifference0.1%

- Check31 days agoChange DetectedThe revision tag on the page history updates from v3.6.0 to v3.6.2, signaling a minor platform update that does not affect study data or content.SummaryDifference0.1%

- Check45 days agoChange DetectedThe study history now shows recruitment has ended, and a new revision label v3.6.0 was added while the previous revision v3.5.5 was removed.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page history shows a new revision tag (v3.5.5) indicating that the study record was updated since the previous version.SummaryDifference0.1%

- Check60 days agoChange DetectedA new version entry (54, dated 2026-05-21) was added to the record history, introducing new sections for Study Status and Study Identification; the entry dated 2025-09-17 was removed.SummaryDifference0.3%

Stay in the know with updates to Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.